February 26, 2020 / 10:38 PM / a month ago

BRIEF-Regenxbio Posts Q4 Loss Per Share Of 72 Cents

Feb 26 (Reuters) - Regenxbio Inc:

* REGENXBIO REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* Q4 LOSS PER SHARE $0.72

* Q4 EARNINGS PER SHARE ESTIMATE $-0.44 — REFINITIV IBES DATA

* REVENUES WERE $11.8 MILLION FOR THREE MONTHS ENDED DECEMBER 31, 2019 COMPARED TO $40.8 MILLION FOR THREE MONTHS ENDED DECEMBER 31, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below